 |
Stéphanie Debette from Lille, France, for her project "Looking for an association of chemokine gene variants with carotid atherosclerosis", which she will carry out at the Centre for Clinical Neuroscience, London, UK, chaired by Prof. Hugh Markus. |
 |
Mariya Petrova from Silistra, Bulgaria, for her project "Clinical, neuropsychological and genetic markers for the early diagnosis of Parkinson's desease dementia", which she will carry out at the Salpetriere Hospital, Paris, France, chaired by Prof. Bruno Dubois. |
 |
Matthieu Rutgers from Brussels, Belgium, for his project "Contrast Extravasation on Computed Tomography in Intracerebral Hemorrhage is an independent factor of haematoma growth and may help detect good candidates for haemostatic therapy: a retrospective and a prospective study", which he will carry out at the University Hospital Lausanne, Switzerland, chaired by Dr. Patrik Michel. |
 |
Ajith Sominanda from Stockholm, Sweden, for his project "Effect of neutralising antibodies against the interferon beta drug on endogenous interferon beta in multiple sclerosis patients", which he will carry out at the University Hospital Düsseldorf, Germany, chaired by Prof. Bernd Kieseier. |
 |
Clotilde Balucani from Perugia, Italy, for her project "cognitive impairment in chronic heart falure patients: exploring the neuropsychological profile, the underlying pathophysiological mechanisms, and the prognostic value", which she will carry out at the University Hospital Lille, FR, chaired by Prof. Didier Leys. |
 |
Konstantinos Papadopoulos from Thessaloniki, Greece, for his project "Neuroinflammation: Quantitative MRI measure lesions of T1 relaxation time in multiple sclerosis and clinical isolated syndrome and their prognostic value", which he will carry out at the UCl Institute of Neurology, London, UK, chaired by Prof. David Miller. |
 |
Natallia Lapitskaya from Aarhus, Denmark for her project "Cortical excitability in severe brain injury: correlation to the level of consciousness and the degree of the underlying structural damage", which she will carry out at the University Hospital Liège, Belgium, chaired by Prof. Gustave Moonen. |
 |
Marlene Tschernatsch, Giessen, Germany for her project "Role of ion channel autoantibodies in NK-cell antibody-dependent anti-tumour immunity in patients with paraneoplastic Lambert-Eaton syndrome", which she will carry out at the University of Oxford, UK, chaird by Prof. Nick Willcox. |